Cover Image

Research on Liver Damage Caused by the Treatment of Rheumatoid Arthritis with Novel Biological Agents or Targeted Agents

Xin Zhao,1 Chenhao Zhang,2 Yi An,3 Zixuan Zhang,3 Jiahe Zhao,3 Xinwen Zhang,3 Yue Yang,4 Wei Cao4 1Department of Rheumatology, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053, People's Republic of China; 2Department of Emergency, Wangjing Hospital of Chin...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhao X (Author), Zhang C (Author), An Y (Author), Zhang Z (Author), Zhao J (Author), Zhang X (Author), Yang Y (Author), Cao W (Author)
Format:	Book
Published:	Dove Medical Press, 2023-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cardiotoxicity in Biological Agent-Targeted Therapy for Rheumatoid Arthritis: ADR Signal Mining and Analysis of Food and Drug Administration Adverse Event Reporting System Database
by: Xiaoyan Tang, et al.
Published: (2021)

Total Alkaloids of Sophora alopecuroides Linn. Attenuates Rheumatoid Arthritis Through Regulating Follicular Helper T Cells
by: Cao G, et al.
Published: (2024)

Application Value of Platelet-to-Lymphocyte Ratio as a Novel Indicator in Rheumatoid Arthritis: A Review Based on Clinical Evidence
by: Liu S, et al.
Published: (2024)

Efficacy of biological agents administered as monotherapy in rheumatoid arthritis: a Bayesian mixed-treatment comparison analysis
by: Migliore A, et al.
Published: (2015)

Norisoboldine Reduces Arthritis Severity by Attenuating Inflammation, Oxidative Stress, and Extracellular Matrix Degradation in a Rat Model of Rheumatoid Arthritis
by: Wang Y, et al.
Published: (2024)

Adverse Events in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Receiving Long-Term Biological Agents in a Real-Life Setting
by: Mayara Costa de Camargo, et al.
Published: (2019)

“PFH/AGM-CBA/HSV-TK/LIPOSOME-Affibody”: Novel Targeted Nano Ultrasound Contrast Agents for Ultrasound Imaging and Inhibited the Growth of ErbB2-Overexpressing Gastric Cancer Cells
by: Zhou H, et al.
Published: (2022)

Economic evaluation of anti-TNF agents for patients with rheumatoid arthritis in Greece
by: Fragoulakis V, et al.
Published: (2015)

Differential Expression Profiles of Plasma Exosomal microRNAs in Rheumatoid Arthritis
by: Yang X, et al.
Published: (2023)

Predictor of joint damage in rheumatoid arthritis
by: Sumariyono Sumariyono, et al.
Published: (2018)

Two Cases of Immune Drift Phenomena Caused by Biologic Agents for Treating Psoriasis and Atopic Dermatitis
by: Ma X, et al.
Published: (2023)

Psoriatic arthritis: treatment strategies using biologic agents
by: C. Palazzi, et al.
Published: (2012)

Synthesis and Biological Evaluations of Monocarbonyl Curcumin Inspired Pyrazole Analogues as Potential Anti-Colon Cancer Agent
by: Min Z, et al.
Published: (2020)

Luobitong Potentiates MTX’s Anti-Rheumatoid Arthritis Activity via Targeting Multiple Inflammatory Pathways
by: Li Z, et al.
Published: (2024)

Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)
by: R. Caporali, et al.
Published: (2011)

Potential Anti-Coronavirus Agents and the Pharmacologic Mechanisms
by: Yang Y, et al.
Published: (2021)

Jintiange Capsule Alleviates Rheumatoid Arthritis and Reverses Changes of Serum Metabolic Profile in Collagen-Induced Arthritic Rats
by: Wang X, et al.
Published: (2021)

Dual-targeting inhibition of TNFR1 for alleviating rheumatoid arthritis by a novel composite nucleic acid nanodrug
by: Xiaonan Wang, et al.
Published: (2023)

Design, Synthesis and Biological Evaluation of Glycosylated Derivatives of Silibinin as Potential Anti-Tumor Agents
by: Xi JJ, et al.
Published: (2023)

Switching to an alternative biological agent in juvenile idiopathic arthritis (I)
by: Gonzalez MI, et al.
Published: (2011)

Targeted therapy of rheumatoid arthritis via macrophage repolarization
by: Xu Zhou, et al.
Published: (2021)

Synthesis and biological evaluation of a novel class of curcumin analogs as anti-inflammatory agents for prevention and treatment of sepsis in mouse model
by: Zhao C, et al.
Published: (2015)

Development of 13-Cys-BBR as an Agent Having Dual Action of Anti-Thrombosis and Anti-Inflammation
by: Li G, et al.
Published: (2020)

Research advances of novel biologic therapeutic agents for lupus nephritis
by: Ruo-xi Li, et al.
Published: (2024)

Kinase inhibitors of the IGF-1R as a potential therapeutic agent for rheumatoid arthritis
by: Hiroshi Tsushima, et al.
Published: (2017)

Advancements in the Study of Biologic Agents in Comorbidities of Psoriasis: A Literature Review
by: Wang Y, et al.
Published: (2023)

Novel Dichloroacetophenone-Based PDHK1 Inhibitors as Potent Anticancer Agents
by: Wu P, et al.
Published: (2024)

Design, synthesis and biological evaluation of novel podophyllotoxin derivatives as tubulin-targeting anticancer agents
by: Yujin Guo, et al.
Published: (2024)

Design, synthesis and biological evaluation of novel bergapten derivatives as potent lipid lowering agents
by: Jian-Hong Lu, et al.
Published: (2015)

Pharmacological Aspects of Natural Quercetin in Rheumatoid Arthritis
by: Tang M, et al.
Published: (2022)

Parthenolide as a potential therapeutic agent for gastric cancer: Exploring oxidative stress and DNA damage
by: Shuhong Zeng, et al.
Published: (2024)

Discovery and biological evaluation of novel CARM1/HDAC2 dual-targeting inhibitors with anti-prostate cancer agents
by: Sudong Liang, et al.
Published: (2023)

Estrogen Protects Articular Cartilage by Downregulating ASIC1a in Rheumatoid Arthritis
by: Hang X, et al.
Published: (2021)

B cell autoimmunity and bone damage in rheumatoid arthritis
by: S. Bugatti, et al.
Published: (2016)

MTHFR and MTRR Genetic Polymorphism of Methotrexate Therapy Outcomes in Early Rheumatoid Arthritis
by: Zhang Q, et al.
Published: (2023)

HUMAN MONOCLONAL ANTIBODIES TO TNF-? - AGENT OF CHOICE IN TREATMENT OF SEVERE JUVENILE RHEUMATOID ARTHRITIS WITH UVEITIS
by: A.O. Lisitsyn, et al.
Published: (2010)

HUMAN MONOCLONAL ANTIBODIES TO TNF-? - AGENT OF CHOICE IN TREATMENT OF SEVERE JUVENILE RHEUMATOID ARTHRITIS WITH UVEITIS
by: A.O. Lisitsyn, et al.
Published: (2010)

Novel mechanistic study of HDAC6 regulation of rheumatoid arthritis via CMA: exploring potential therapeutic targets
by: Duoduo Lin, et al.
Published: (2024)

Novel autoantibodies in rheumatoid arthritis
by: A.F. Bonifacio, et al.
Published: (2019)

Synthesis of some Novel Nitrogenous Heterocyclic Compounds with Expected Biological Activity as Antimicrobial and Cytotoxic Agents.
by: Mohammed S. Farhan, et al.
Published: (2017)